When was Clozex founded?

Clozex was founded in 2003 and raised its 1st funding round 16 years after it was founded.

Where is Clozex located?

Clozex is headquartered in Wellesley, United States.

How many employees does Clozex have?

As of Oct 31, 2026, the latest employee count at Clozex is 10.

Is Clozex a funded company?

Clozex is a funded company, having raised a total of $4.48M across 3 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Jun 12, 2019.

When was the latest funding round of Clozex?

Clozex's latest funding was a $***** Conventional Debt round on Nov 01, 2023, with participation from 0 investor.

Where does Clozex rank among its competitors?

Clozex ranks 8th amongst 21 active competitors, of which 10 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was TYBR Health, which secured $30M in Jul, 2026.

Who are the top competitors of Clozex?

Clozex's top competitors include TYBR Health, Cousin Surgery and Neomend. Among them, TYBR Health secured the most recent funding round in July, 2026.

Clozex - 2026 Company Profile, Team, Funding & Competitors

Company Details

Innovative skin closure devices for advanced wound care and surgical solutions. They focus on designing and developing devices that improve clinical outcomes and enhance procedural efficiencies during surgical skin closure. Their closures address the limitations of traditional suture and staple-based technologies, offering a faster and more controlled solution with exceptional cosmetic results. The patented Interlaced Locking Technology approximates skin edges and provides three-dimensional control of the wound. The non-invasive adhesive pads reduce tension on wound edges, minimizing scarring for patients. The system creates a cross-incisional zone of healing, securely locking the pads in place throughout the wound healing process. Their closures have been validated by clinical studies and are a Class I device with regulatory clearance, sterile, and latex-free. They are an emerging leader in the development and manufacture of innovative skin closure devices for advanced wound care, surgical incisions, and traumatic lacerations.

Key Metrics

Founded Year

2003

Location

Wellesley, United States

Stage

Series A

Total Funding

$4.48M in 3 rounds

Latest Funding Round

Conventional Debt, Nov 01, 2023, $*****

Ranked

8^th among 21 active competitors

Employee Count

10 as on Oct 31, 2026

Similar Companies

TYBR Health & 25 more

View Clozex's full profile

Clozex has raised a total funding of $4.48M over 3 rounds. Its first funding round was on Jun 12, 2019.

Here is the list of recent funding rounds of Clozex:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 01, 2023	8259714	Conventional Debt	5395220	3612564	3086659	4000716
Feb 04, 2021	5629712	Conventional Debt	2714188	6509019	9894487	5873852
Jun 12, 2019	6963402	Series A	3674633	2648213	1445732	1836539

Access funding benchmarks and valuations. Sign up today!

View details of Clozex's funding rounds and investors

The founders of Clozex is Michael Lebner.

Here are the details of Clozex's key team members:

Michael Lebner: Founder & Director of Clozex.

View details of Clozex's Founder profiles and Board Members

Clozex's employee count trend

Clozex has 10 employees as of Oct 26. Here is Clozex's employee count trend over the years:

Uncover Clozex's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Clozex include TYBR Health, Cousin Surgery and Neomend. Here is the list of Top 10 competitors of Clozex, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	TYBR Health 2020, Houston (United States), Series A	Provider of regenrative medicine for post surgical scarring	$38.4M	Vensana Capital, Y Combinator & 4 others	56/100
2nd	Cousin Surgery 1848, Wervicq Sud (France), Unfunded	Manufacturer of implantable textile medical devices for spine and visceral surgery. It develops innovative implants to advance visceral and spine surgery, focusing on preserving mobility and reducing post-operative pain. The company collaborates closely with surgeons and utilizes unique expertise in implantable textiles. Its product portfolio includes solutions for various surgical specialties, such as orthopedics, uro-gynecology, and bariatric surgery, along with adhesion prevention and hemostasis products. The company also offers subcontracting services and technological support.	-	Turenne Groupe, Nord Capital Partenaires	45/100
3rd	Neomend 1999, Irvine (United States), Acquired	Provider of air leak sealant for thoracic surgery	$38.8M	Vivo Capital, Novo Holdings & 4 others	43/100
4th	Sylke 2023, La Jolla (United States), Series B	Provider of medical device company	$15.5M	Vaark	40/100
5th	Tissuemed 1985, Leeds (United Kingdom), Acqui-Hired	Bioadhesive films to prevent body fluid and air leakage during surgery	$12.7M	Saints Capital, Shackleton Ventures & 5 others	39/100
6th	BioDevek 2014, Boston (United States), Funding Raised	Developer of next generation of surgical sealant solutions	-	MedTech Innovator, National Science Foundation ... & 1 others	38/100
7th	GATT Technologies BV 2011, Nijmegen (Netherlands), Series B	Polymer-based General Adhesive Tissue Tape	$11.4M	EIC Fund, Johnson & Johnson Innovation & 3 others	37/100
8th	Clozex 2003, Wellesley (United States), Series A	Innovative skin closure devices for advanced wound care and surgical solutions	$4.48M	-	35/100
9th	Sealonix 2023, Bedford (United States), Series A	Developer of hemostatic sealants for surgeries	$20M	Excelestar Ventures, AMED Ventures & 4 others	36/100
10th	Cohera Medical 2006, Pittsburgh (United States), Deadpooled	Developer of surgical adhesives and sealants	$136M	KKR, H.I.G. Private Equity & 5 others	35/100